RFP, CGN and CGA Opportunities
The Alliance is a community dedicated to connecting healthcare education professionals to promote best practices that improve patient care. To help achieve this, we collect information on research proposals and grants offered through other healthcare-related organizations. If your company is interested in posting a request for grant applications, please contact the Alliance Business Office at firstname.lastname@example.org.
Call for Grant Application (CGA): Currently Astellas does not have an open CGA however unsolicited requests can be submitted at www.astellasgrants.com.
All questions can be sent to Astellas IME at email@example.com.
Biogen considers requests for independent medical education activities within the disease areas listed below. As areas of interest may change periodically, please consult the Biogen Grants and Giving website for the most up to date information. Please note that the submission and review process for international funding opportunities differ.
- Alzheimer’s Disease
For additional information on the Biogen grant submission process, please visit our website.
Bristol-Myers Squibb accepts funding requests within the following therapeutic areas of interest. As areas of interest and funding consideration may change periodically, please consult this website frequently. Please note that international funding opportunities may differ.
- Genetically Defined / Rare Diseases
Eli Lilly and Company
LINK to Lilly Grant Office portal
Therapeutic area of interest: Oncology
Genentech is seeking to support learning initiatives that demonstrate a strategy that evolves knowledge-based medical education into a “healthcare Improvement” initiative that accelerates the awareness and application of evidence-based medicine, resulting in appropriate care for patients and relevant, measurable, clinical outcomes.
Call for Grant Notification Focus Area: Telemedicine in Neurology
Issue Date: February 26, 2021
Deadline: March 19, 2021
Click here to learn more about the call for notification application.
To view other opportunities and complete details regarding grant submission, please visit Genentech.
GRAIL is committed to funding innovative and impactful education to support practicing healthcare professionals and the communities of care that they manage within our areas of interest. GRAIL is open to the receipt of unsolicited Independent Medical Education grants. To inquire further please reach out to firstname.lastname@example.org.
Current areas of interest
- Multi-Cancer Early Detection
- Clinical Suspicion of Cancer
To apply for funding, and for more information regarding our areas of interest, including example educational objectives, please visit www.grail.com/meded.
Current GRAIL CGAs
Additional CGAs to come in early 2021
Indivior supports independent medical education activities that provide for an increased understanding of scientific, clinical, or healthcare issues related to the company’s therapeutic areas of interest.
Therapeutic areas of interest:
- Opioid Use Disorder
To view open RFPs and complete details regarding grant submission, please visit the following site on a regular basis: grants.indivior.com
Jazz Pharmaceuticals is committed to improving patient outcomes and providing support in compliance with local regulations. The Jazz grant management system is currently accepting requests for medical education meetings, conferences, or symposia; medical center grand rounds lectures; fellowships; enduring medical education activities; and similar educational activities. In Europe and Rest of World (EU/RoW) the system is also accepting requests for goods (such as books, printing, materials, equipment) and services (such as administrative support, personnel, and tools).
Therapeutic areas of interest:
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
The Centers for Medicare & Medicaid Services (CMS) recognizes the benefits of measure development by external stakeholders with specific knowledge of clinician and patient perspectives and needs, such as clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities.
On March 2, 2018, CMS published the “Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program” on Grants.gov. The purpose of this Funding Opportunity is to provide technical and funding assistance in the form of cooperative agreements to entities to develop, improve, update, or expand quality measures for use in the Quality Payment Program (QPP).
For more information and to see the ‘Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program’ search by the title or the Catalog of Federal Domestic Assistance (CFDA) number, 93.986 on Grants.gov.
Novo Nordisk Inc.
Novo Nordisk is committed to supporting independent medical education programs that meet the educational needs of health care professionals (HCPs), patients and the community in ways that measurably grow their knowledge and skills to optimize patient or self care in the following therapeutic areas of interest:
Please visit www.novonordiskgrants.com to apply for educational grants and access the IME Funding Document that provides information about educational priorities and available funding as well as current Request for Proposals (RFPs)/Call for Concept Proposals (CCPs) within these therapeutic areas.
Pfizer Independent Grants for Learning & Change (IGLC)
The mission of Pfizer Independent Grants for Learning & Change is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. The Joint Commission is an independent, not-for-profit organization that accredits and certifies nearly 21,000 health care organizations and programs in the United States.
To view open RFPs and complete details, please visit this webpage.
The Regeneron and Sanofi Genzyme Alliance seeks to close important medical educational gaps with regard to Advanced Basal Cell Carcinoma (BCC) through consideration of grant proposals for 2020-2021 independent medical education activities. Target audiences include Dermato-Oncologist, Oncologists, Dermatologists, Mohs surgeons (US Only), Pharmacists, Registered Nurses, and advanced-level practitioners via live and enduring distribution channels; please refer to the Request for Proposal for further details.
Request for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Programs at ISTH and/or ASH 2021
To respond to this RFP, please complete the Independent Medical Education application at: https://sgrants.envisionpharma.com/vt_sgrants/
When entering proposal into the website, please reference the following:
Therapeutic Area: Rare Blood Disorders
Area of Interest: aTTP
RFP Name: “aTTP 2021”
RFP Due Date: March 10, 2021 No Later than 5 PM ET
Please note that you must answer the question, “Are you responding to an RFP” and select “aTTP 2021” from the RFP dropdown panel within the grant portal upon submitting your application for this RFP.
Shionogi accepts funding requests within the following therapeutic areas of interest.
- Gram-negative multidrug-resistant infectious disease (ID)
- Thrombocytopenia associated with chronic liver disease (CLD)
- Opioid-induced Constipation (OIC)
The call for grants (CFG) opportunities will change on a quarterly basis. Please consult our website to identify current opportunities.
TRC Healthcare (TRC), the creators of Pharmacist’s Letter, is committed to helping clinicians and healthcare professionals make safe, effective, and efficient medication decisions.
To learn more about TRC and view open RFPs, please visit TRC Healthcare.